AHA 2025 Archives - Medical Conferences

Home > Cardiology > AHA 2025

Read the full Report (pdf)

American Heart Society Scientific Sessions 2025 7-10 November 2025 New Orleans, Louisiana, USA

Clear winner in post-PCI head-to-head trial

Presented By

Dr Sripal Bangalore , New York University School of Medicine, NY, USA

Conference

AHA 2025

Type

News article

5 December 2025 14:12

New subcutaneous drug improves outcomes in STEMI patients

Presented By

Prof. Arnoud van ‘t Hof , Maastricht University, the Netherlands

Conference

AHA 2025

Type

News article

5 December 2025 14:11

AHA 2025 Highlights Podcast

Presented By

Dr Rachel Giles and Robert van den Heuvel, Medicom

Conference

AHA 2025

24 November 2025 14:55

Online First

Valvular Heart Disease and Hypertrophic Cardiomyopathy

New treatment strategy saves lives in aortic stenosis

Presented By

Dr Duk-Hyun Kang , Asan Medical Center, South Korea

Conference

AHA 2025

Type

News article

5 December 2025 14:20

First-in-class gene therapy for HCM

Presented By

Dr Milind Desai , Cleveland Clinic, OH, USA

Conference

AHA 2025

Type

News article

5 December 2025 14:19

Innovative CABG procedure reduces morbidity in a specific population

Presented By

Prof. Qiang Zhao , Ruijin Hospital Shanghai JiaoTong University School of Medicine, China

Conference

AHA 2025

Type

News article

5 December 2025 14:19

Cardiometabolic Risk Mitigation

Pharmacological intervention tested in cardiac allograft vasculopathy

Presented By

Prof. William Fearon , Stanford University, CA, USA

Conference

AHA 2025

Type

News article

5 December 2025 14:07

Clear-cut results from a large PCSK9 inhibition trial in high-risk ASCVD

Presented By

Dr Erin Bohula , Brigham and Women’s Hospital, MA, USA

Conference

AHA 2025

Type

News article

5 December 2025 14:06

Highly promising one-time treatment for hyperlipidaemia

Presented By

Prof. Stephen Nicholls , Monash University, Australia

Conference

AHA 2025

Type

News article

5 December 2025 14:05

New hypertriglyceridemia drug prevents dangerous condition

Presented By

Dr Nicholas Marston , Brigham and Women’s Hospital, MA, USA

Conference

AHA 2025

Type

News article

5 December 2025 14:04

First-in-class therapeutic yields remarkable improvements in hypertriglyceridemia

Presented By

Prof. Jianping Li , Peking University First Hospital, China

Conference

AHA 2025

Type

News article

5 December 2025 14:03

Heart Failure Treatment Strategies

Is the new ‘super-pill’ for HF ready for prime time?

Presented By

Dr Ambarish Pandey , University of Texas, TX, USA

Conference

AHA 2025

Type

News article

5 December 2025 14:09

GLP-1 receptor agonists go head-to-head

Presented By

Prof. Stephen Nicholls, Monash University, Australia

Conference

AHA 2025

Type

News article

5 December 2025 14:08

Coronary Artery Disease

Clear winner in post-PCI head-to-head trial

Presented By

Dr Sripal Bangalore , New York University School of Medicine, NY, USA

Conference

AHA 2025

Type

News article

5 December 2025 14:12

New subcutaneous drug improves outcomes in STEMI patients

Presented By

Prof. Arnoud van ‘t Hof , Maastricht University, the Netherlands

Conference

AHA 2025

Type

News article

5 December 2025 14:11

Atrial Fibrillation

Is anticoagulation really needed after successful AF ablation?

Presented By

Prof. Atul Verma, McGill University, Canada

Conference

AHA 2025

Type

News article

5 December 2025 14:16

Counterintuitive result for coffee consumption in AF patients

Presented By

Prof. Christopher Wong , University of Adelaide, Australia

Conference

AHA 2025

Type

Peer-reviewed article

5 December 2025 14:15

Mono- or dual antithrombotic therapy beyond 1-year post-PCI in AF patients?

Presented By

Prof. Jung-Sun Kim , Yonsei University College of Medicine, South Korea

Conference

AHA 2025

Type

News article

5 December 2025 14:15

Can we reduce AF recurrence after ablation?

Presented By

Dr Zixu Zhao , Beijing Anzhen Hospital, China

Conference

AHA 2025

Type

News article

5 December 2025 14:14

Innovative method to manage high-risk AF under investigation

Presented By

Prof. Ulf Landmesser , Charité University of Medicine Berlin, Germany

Conference

AHA 2025

Type

News article

5 December 2025 14:13

Encouraging results from a novel antithrombotic strategy in AF after PCI

Presented By

Dr Yohei Sotomi , University of Osaka, Japan

Conference

AHA 2025

Type

News article

5 December 2025 14:12

Blood Pressure Control

Innovative strategy reduces BP in low-resource areas

Presented By

Dr Stephen Juraschek , Beth Israel Deaconess Medical Center, MA, USA

Conference

AHA 2025

Type

Peer-reviewed article

5 December 2025 14:18

Interesting family-based approach to lower BP

Presented By

Prof. Jun Cai , Beijing Anzhen Hospital, China

Conference

AHA 2025

Type

Peer-reviewed article

5 December 2025 14:17

Medical Conferences

AHA 2025

Featured articles

Clear winner in post-PCI head-to-head trial

New subcutaneous drug improves outcomes in STEMI patients

AHA 2025 Highlights Podcast

CONTENTS

Online First

Valvular Heart Disease and Hypertrophic Cardiomyopathy

New treatment strategy saves lives in aortic stenosis

First-in-class gene therapy for HCM

Innovative CABG procedure reduces morbidity in a specific population

Cardiometabolic Risk Mitigation

Pharmacological intervention tested in cardiac allograft vasculopathy

Clear-cut results from a large PCSK9 inhibition trial in high-risk ASCVD

Highly promising one-time treatment for hyperlipidaemia

New hypertriglyceridemia drug prevents dangerous condition

First-in-class therapeutic yields remarkable improvements in hypertriglyceridemia

Heart Failure Treatment Strategies

Is the new ‘super-pill’ for HF ready for prime time?

GLP-1 receptor agonists go head-to-head

Coronary Artery Disease

Clear winner in post-PCI head-to-head trial

New subcutaneous drug improves outcomes in STEMI patients

Atrial Fibrillation

Is anticoagulation really needed after successful AF ablation?

Counterintuitive result for coffee consumption in AF patients

Mono- or dual antithrombotic therapy beyond 1-year post-PCI in AF patients?

Can we reduce AF recurrence after ablation?

Innovative method to manage high-risk AF under investigation

Encouraging results from a novel antithrombotic strategy in AF after PCI

Blood Pressure Control

Innovative strategy reduces BP in low-resource areas

Interesting family-based approach to lower BP